Search results
Author(s):
Abhishek Maan
,
Moussa Mansour
,
Jeremy N Ruskin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice.1 It has been estimated that >3million people in the US and >4.5 million in the EU have paroxysmal or persistent AF.2–4 AF is associated with an approximately fivefold increased risk of stroke,5 threefold risk of heart failure,6 diminished quality of life7 and increased healthcare costs.8,9…
View more
Author(s):
Alex Baher
,
Nassir F Marrouche
Added:
3 years ago
AF is the most common rhythm disorder. It is estimated AF will affect 6–12 million Americans by 2050 and 17.9 million Europeans by 2060.1–4 AF is responsible for significant morbidity, mortality and healthcare costs.5–7 Heart failure with reduced ejection fraction (HFrEF) is also a rising epidemic that will afflict over 8 million Americans by 2030.8 AF is common in patients with HFrEF9,10 and…
View more
Author(s):
Dimitrios Vrachatis
,
Spyridon Deftereos
,
Vasileios Kekeris
,
et al
Added:
3 years ago
Heart failure (HF) and AF share common pathophysiologic pathways and often coexist.1 Indeed, HF has been identified as the strongest predictor of AF in a Framingham Heart study population-based cohort.2 Moreover, HF and AF are involved in a vicious pathophysiological interplay. HF promotes AF mainly through raised atrial filling pressures, abnormal calcium handling, neurohormonal activation and…
View more
Author(s):
Samuel Lévy
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice and may be associated with symptoms, haemodynamic impairment and frightening embolic complications. In 1998 recommendations on the management of AF were reported by the Working Group of Arrhythmias of the European Society of Cardiology (ESC). 1 The American College of Cardiology (ACC), the American…
View more
Rhythm Control in AF-CHF
Author(s):
William Eysenck
,
Magdi Saba
Added:
3 years ago
Article
Author(s):
Sandeep Prabhu
,
Wei H Lim
Added:
3 years ago
Heart failure (HF) and AF are two conditions that are increasing in prevalence worldwide.1,2 They frequently co-exist and in recent years, the clinical and physiological intersection between arrhythmia and HF has become an area of renewed interest, particularly as interventional treatments for rhythm disorders have advanced and moved into the mainstream of cardiac management. In particular, AF,…
View more
Author(s):
Nikki Pluymaekers
,
Astrid Hermans
,
Dominik Linz
,
et al
Added:
3 years ago
Author(s):
Rahul K Mukherjee
,
Steven E Williams
,
Steve Niederer
,
et al
Added:
3 years ago
AF is the most common cardiac arrhythmia of clinical significance with an estimated prevalence of >33 million individuals globally.1 AF can be associated with significant symptoms and impaired quality of life of affected patients while also increasing the risk of stroke, heart failure and death.2 AF frequently co-exists with heart failure (HF). Up to half of patients with HF in the Framingham…
View more
Author(s):
Mahmoud Abdelnabi
,
Ashraf Ahmed
,
Abdallah Almaghraby
,
et al
Added:
3 years ago
Ivabradine is a pure heart rate-lowering agent best characterised by its negative chronotropic effect on the sinoatrial node.1 Its unique mechanism selectively blocks the pacemaker funny (If) channels, which are responsible for spontaneous depolarisation in the sinoatrial node that regulates heart rate during sinus rhythm (Figure 1).2 Since 1980, it has been well established that controlling the…
View more
Author(s):
Andrew Y Chang
,
Daniel Kaiser
,
Aditya Ullal
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most frequently encountered arrhythmia in clinical practice.1,2 The prevalence of AF in the United States ranges from 2.7 to 6.1 million, with 5.6 to 12 million additional cases projected by 2050.1 Medicare spending for new AF diagnoses has reached $15.7 billion per year as extrapolated from a 2004–2006 dataset, primarily driven by its complications (e.g. stroke,…
View more